Dexcom (DXCM) Other Non-Current Liabilities (2010 - 2026)

Dexcom (DXCM) has reported Other Non-Current Liabilities for 17 consecutive years, with $150.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Non-Current Liabilities fell 0.53% year-over-year to $150.8 million in Q2 2026; TTM through Jun 2026 was $150.8 million, a 0.53% decrease from a year earlier, with the FY2025 full-year figure at $137.1 million, down 7.3% from the prior year.
• Other Non-Current Liabilities was $150.8 million for Q2 2026 at Dexcom, up from $141.8 million in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $151.6 million in Q2 2025 and troughed at $97.1 million in Q1 2022.
• A 5-year average of $132.5 million and a median of $131.4 million in 2023 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities surged 42.56% in 2022 and declined 7.3% in 2025, its largest moves.
• Over 5 years, Other Non-Current Liabilities stood at $128.3 million in 2022, then fell by 2.1% to $125.6 million in 2023, then rose by 17.75% to $147.9 million in 2024, then retreated by 7.3% to $137.1 million in 2025, then rose by 9.99% to $150.8 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $150.8 million (Q2 2026), $141.8 million (Q1 2026), and $137.1 million (Q4 2025), per Business Quant data.